VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Look at the big picture

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Mar 25, 2021 2:39pm

130 Views

Post# 32876838

RE:RE:RE:RE:RE:RE:Look at the big picture

I see a reference to a Dr. KSS over on the C.AGN board. If it's the same Dr. he does seem to spread himself around - but then maybe there is more than one Dr. KSS.

snuff133 wrote: Dear Friend;

I have approval to invite you to attend the BioPub event today at noon EST (see below). There is no charge but you will be asked your email address when you join.

Dr. KSS has been providing in-depth analysis of medical breakthrough companies for 8 years and has built up large following, which includes investors in 40 countries.

I presented to this group last fall and it is time for an update. As an added bonus, Dr. Gregory Skinner, the head of echocardiolography at Glenfield Children’s Hospital in the UK will be joining the panel. He will be relating his 5-year experience using the VMS in children and how it has allowed him to build a pan-European and Middle-East referral practice. He sees children from many countries due to the ability of the VMS to obtain the same information as MRI without the negative impact children experience in MRI exams.

Being in the UK, he does the scans himself and also does cardiac MRI himself so can speak directly to why he finds the VMS so useful. I am sure you will enjoy his perspective in this informal discussion with Dr. KSS and myself.

The session will be recorded and you can view it later on BioPUb website if noon is not convenient. I will send out the link when I get it.

Regards,